Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Skvortsov

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Journal of Clinical and Experimental Neuropsychology|March 15, 2017
Preliminary validation study of the Russian Birmingham Cognitive ScreenE Kuzmina, G W Humphreys, M J Riddoch, et al.
Terapevticheskii Arkhiv|January 1, 1989
[New approaches to the study of thrombocyte aggregation in patients with dilated cardiomyopathy]A A Skvortsov, Z A Gabbasov, E G Popov, et al.
Kardiologiia|February 12, 2008
[Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy]A A Skvortsov, V Yu Mareev, S M Chelmakina, et al.
Kardiologiia|March 16, 2017
[The Role of Markers of Organ Damage in Patients With Chronic Heart Failure]D E Koshkina, A A Skvortsov, V N Protasov, et al.
Kardiologiia|July 31, 2012
[Galectin 3--a new biomarker for diagnostics and outcome of chronic heart failure]S V Lakomkin, A A Skvortsov, T V Goriunova, et al.
Angiologiia I Sosudistaia Khirurgiia = Angiology and Vascular Surgery|December 10, 2014
[Hybrid technology in repeat operation of a patient with aortic arch aneurysm and type A chronic aortic dissection]É R Charchian, S A Abugov, A A Skvortsov, et al.
Terapevticheskii Arkhiv|April 27, 2011
[Baroreflex sensitivity in patients with chronic heart failure: the clinical significance and impact of therapy]M V Nepoklonov, A N Rogoza, A A Skvortsov, et al.
Kardiologiia|November 29, 2011
[The role of hypotension as a factor of unfavorable prognosis in patients with chronic heart failure]L G Kapanadze, A A Petrukhina, S N Nasonova, et al.
Kardiologiia|June 9, 2015
[The role of markers of organ damage in patients with chronic heart failure]L E Koshkina, A A Skvortsov, V N Protasov, et al.
Kardiologiia|March 21, 2014
[Treatment of patients with chronic heart failure based on monitoring of concentrations of natriuretic peptides--to what extent it is justified in clinical practice?]A A Skvortsov, D E Koshkina, O Iu Narusov, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical and Experimental Neuropsychology|March 15, 2017
Preliminary validation study of the Russian Birmingham Cognitive ScreenE Kuzmina, G W Humphreys, M J Riddoch, et al.
Terapevticheskii Arkhiv|January 1, 1989
[New approaches to the study of thrombocyte aggregation in patients with dilated cardiomyopathy]A A Skvortsov, Z A Gabbasov, E G Popov, et al.
Kardiologiia|February 12, 2008
[Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy]A A Skvortsov, V Yu Mareev, S M Chelmakina, et al.
Kardiologiia|March 16, 2017
[The Role of Markers of Organ Damage in Patients With Chronic Heart Failure]D E Koshkina, A A Skvortsov, V N Protasov, et al.
Kardiologiia|July 31, 2012
[Galectin 3--a new biomarker for diagnostics and outcome of chronic heart failure]S V Lakomkin, A A Skvortsov, T V Goriunova, et al.
Angiologiia I Sosudistaia Khirurgiia = Angiology and Vascular Surgery|December 10, 2014
[Hybrid technology in repeat operation of a patient with aortic arch aneurysm and type A chronic aortic dissection]É R Charchian, S A Abugov, A A Skvortsov, et al.
Terapevticheskii Arkhiv|April 27, 2011
[Baroreflex sensitivity in patients with chronic heart failure: the clinical significance and impact of therapy]M V Nepoklonov, A N Rogoza, A A Skvortsov, et al.
Kardiologiia|November 29, 2011
[The role of hypotension as a factor of unfavorable prognosis in patients with chronic heart failure]L G Kapanadze, A A Petrukhina, S N Nasonova, et al.
Kardiologiia|June 9, 2015
[The role of markers of organ damage in patients with chronic heart failure]L E Koshkina, A A Skvortsov, V N Protasov, et al.
Kardiologiia|March 21, 2014
[Treatment of patients with chronic heart failure based on monitoring of concentrations of natriuretic peptides--to what extent it is justified in clinical practice?]A A Skvortsov, D E Koshkina, O Iu Narusov, et al.
Pageof 5